http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Company’s Reduced Nicotine Content Cigarettes
-
22nd Century Group (XXII) Achieves Breakthrough Hemp/Cannabis GMO Technology; Granted New Patent for Controlling Genes Responsible for Production of CBD, THC, and Other Valuable Cannabinoids
-
22nd Century Group Achieves Breakthrough Hemp/Cannabis GMO Technology; Granted New Patent for Controlling Genes Responsible for Production of CBD, THC, and Other Valuable Cannabinoids
-
22nd Century (XXII) Receives Order for 3.6 Million New SPECTRUM Variable Nicotine Cigarettes for U.S. Government-Supported Research
-
22nd Century Receives Order for 3.6 Million New SPECTRUM® Variable Nicotine Cigarettes for U.S. Government-Supported Research
-
22nd Century Group to Present at 13th Annual LD Micro Main Event Conference
-
22nd Century’s Vice President of Regulatory Science Publishes Important Public Policy Article
-
22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference
-
22nd Century Group to Present at the Virtual Fall Investor Summit on November 17
-
22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020
-
22nd Century Group to Host Third Quarter 2020 Webcast and Conduct Quarterly Q&A
-
22nd Century Group to Highlight its Reduced Nicotine Technology at The Food and Drug Law Institute’s Tobacco and Nicotine Products Regulation and Policy Conference
-
22nd Century Group Achieves Breakthrough Technology; Granted New Patent for Reducing Nicotine in Tobacco Plants
-
22nd Century Group Provides Strategy Update Letter from CEO
-
22nd Century Group (XXII) Announces Dr. Michael Koganov to Board
-
22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors
-
22nd Century Group to Present at the LD Micro 500 Virtual Conference
-
22nd Century Group Reports Financial Results and Business Highlights for the Second Quarter 2020
-
22nd Century Group to Host Webcast of 2020 Second Quarter Results
-
22nd Century Group (XXII) Announces James A. Mish as CEO and John Franzino as CFO
-
22nd Century Group Appoints James A. Mish as Chief Executive Officer and John Franzino as Chief Financial Officer
-
22nd Century Group Reports First Quarter 2020 Financial Results
-
22nd Century Group (XXII) Completes Successful Non-GMO Very Low Nicotine Content Tobacco Research Field Trials
-
22nd Century Group Completes Successful Non-GMO Very Low Nicotine Content Tobacco Research Field Trials
-
22nd Century Group to Announce First Quarter 2020 Financial Results on May 7, 2020
-
22nd Century Group (XXII) Reports FDA Announces Deadline to Submit Comments on its MRTP Application
-
FDA Announces Deadline to Submit Comments on 22nd Century Group’s MRTP Application
-
22nd Century Group to Hold Virtual Annual Meeting of Stockholders
-
22nd Century Group, Inc. Files 2019 Annual Report
-
22nd Century Announces Important New Achievements with KeyGene
-
22nd Century Group Adds to Leadership Team
-
CORRECTION: Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use of Very Low Nicotine Content Cigarettes Does Not Lead to Compensatory Smoking
-
Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use
-
FDA Remains Firmly Committed to Nicotine Reduction in Cigarettes
-
Pre-Open Movers 05/01: (OCN) (XXII) (TWTR) Higher; (FNBC) (AEZS) (ITCI) Lower (more...)
-
22nd Century Group Files First Quarter 2015 Financial Results And Announces Conference Call to Provide Business Update

